pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·May 1·1 min read
save

Boehringer appoints pharma veteran for corporate affairs post; BlueRock CSO heads for the exit

→ Boehringer Ingelheim has brought in Christie Bloomquist as SVP, corporate affairs, US human pharma, and she’ll be president of the Boehringer Cares Foundation. Peer Review informed you about her move to ...

May 1, 2026·read at Endpoints ↗

May 1, 2026 07:00 AM EDT Peer Review Boehringer ap­points phar­ma vet­er­an for cor­po­rate af­fairs post; Blue­Rock CSO heads for the ex­it Alex Hoffman Copy Chief Kyle LaHucik Biotech Correspondent → Boehringer In­gel­heim has brought in Christie Bloomquist as SVP, cor­po­rate af­fairs, US hu­man phar­ma, and she’ll be pres­i­dent of the Boehringer Cares Foun­da­tion. Peer … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
90 words · retrieved May 1
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
BOEHRINGER INGELHEIMBoehringer Ingelheim Corp

related stories

  • Aug 18Leo Pharma buys rare skin disease drug in $435M dealBioPharma Dive
  • Aug 18LEO adds to dermatology portfolio with $435M deal for late-stage rare disease drugBioSpace
  • Aug 17Leo ‘really strengthening’ pipeline with $435M deal for Tanabe rare skin disease drug awaiting FDA nodFierce Biotech
  • Aug 17Lilly pens $370M deal with OmniAb for ion channel collab, but details remain vagueFierce Biotech
  • Aug 13Zealand sells its rights to Takeda’s blood cancer drug for $100M ahead of FDA approval decisionFierce Biotech